TY - JOUR
T1 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Infection and Humoral Responses Against Different Variants of Concern in Domestic Pet Animals and Stray Cats from North-Eastern Spain
AU - Fernández-Bastit, Leira
AU - Marfil, Silvia
AU - Pradenas, Edwards
AU - Valle, Rosa
AU - Roca, Núria
AU - Rodon, Jordi
AU - Pailler-García, Lola
AU - Trinité, Benjamin
AU - Parera, Mariona
AU - Noguera-Julian, Marc
AU - Martorell, Jaume
AU - Izquierdo-Useros, Nuria
AU - Carrillo, Jorge
AU - Clotet, Bonaventura
AU - Blanco, Julià
AU - Vergara-Alert, Júlia
AU - Segalés, Joaquim
N1 - Publisher Copyright:
© 2022 The Authors. Transboundary and Emerging Diseases published by Wiley-VCH GmbH.
© 2022 The Authors. Transboundary and Emerging Diseases published by Wiley-VCH GmbH.
PY - 2022/10/7
Y1 - 2022/10/7
N2 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the coronavirus disease 2019 (COVID-19) pandemic in humans, is able to infect several domestic, captive and wildlife animal species. Since reverse zoonotic transmission to pets has been demonstrated, it is crucial to determine their role in the epidemiology of the disease to prevent further spillover events and major spread of SARS-CoV-2. In the present study, we determined the presence of virus and the seroprevalence to SARS-CoV-2, as well as the levels of neutralizing antibodies (nAbs) against several variants of concern (VOCs) in pets (cats, dogs and ferrets) and stray cats from North-Eastern of Spain. We confirmed that cats and dogs can be infected by different VOCs of SARS-CoV-2 and, together with ferrets, are able to develop nAbs against the ancestral (B.1), Alpha (B.1.1.7), Beta (B.1.315), Delta (B.1.617.2) and Omicron (BA.1) variants, with lower titres against the latest in dogs and cats, but not in ferrets. Although the prevalence of active SARS-CoV-2 infection measured as direct viral RNA detection was low (0.3%), presence of nAbs in pets living in COVID-19-positive households was relatively high (close to 25% in cats, 10% in dogs and 40% in ferrets). It is essential to continue monitoring SARS-CoV-2 infections in these animals due to their frequent contact with human populations, and we cannot discard the probability of a higher animal susceptibility to new potential SARS-CoV-2 VOCs.
AB - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the coronavirus disease 2019 (COVID-19) pandemic in humans, is able to infect several domestic, captive and wildlife animal species. Since reverse zoonotic transmission to pets has been demonstrated, it is crucial to determine their role in the epidemiology of the disease to prevent further spillover events and major spread of SARS-CoV-2. In the present study, we determined the presence of virus and the seroprevalence to SARS-CoV-2, as well as the levels of neutralizing antibodies (nAbs) against several variants of concern (VOCs) in pets (cats, dogs and ferrets) and stray cats from North-Eastern of Spain. We confirmed that cats and dogs can be infected by different VOCs of SARS-CoV-2 and, together with ferrets, are able to develop nAbs against the ancestral (B.1), Alpha (B.1.1.7), Beta (B.1.315), Delta (B.1.617.2) and Omicron (BA.1) variants, with lower titres against the latest in dogs and cats, but not in ferrets. Although the prevalence of active SARS-CoV-2 infection measured as direct viral RNA detection was low (0.3%), presence of nAbs in pets living in COVID-19-positive households was relatively high (close to 25% in cats, 10% in dogs and 40% in ferrets). It is essential to continue monitoring SARS-CoV-2 infections in these animals due to their frequent contact with human populations, and we cannot discard the probability of a higher animal susceptibility to new potential SARS-CoV-2 VOCs.
KW - coronavirus disease 2019 (COVID-19)
KW - pets
KW - severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
KW - stray cats
KW - variants of concern (VOCs)
KW - zoonotic transmission
UR - http://www.scopus.com/inward/record.url?scp=85139447858&partnerID=8YFLogxK
U2 - 10.1111/tbed.14714
DO - 10.1111/tbed.14714
M3 - Article
C2 - 36167932
SN - 1865-1674
JO - Transboundary and emerging diseases
JF - Transboundary and emerging diseases
ER -